Episodes

  • Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data

    Advances in the Pharmacologic Management of Obesity: An Expert Digest of the Latest Data
    Nov 27 2025

    Are you up to date on emerging pharmacologic therapies transforming obesity and type 2 diabetes care?

    Credit available for this activity expires: 11/28/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advances-pharmacologic-management-obesity-expert-digest-2025a1000v94
    Show More Show Less
    16 mins
  • Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies

    Breaking the Silence: Tackling Liver Fibrosis in MASH: Who to Treat With Novel Therapies
    Nov 25 2025
    Do you know whom to treat and why? Learn about identifying and treating at-risk metabolic dysfunction-associated steatohepatitis (MASH).

    Credit available for this activity expires: 11/25/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-silence-tackling-liver-fibrosis-mash-who-treat-2025a1000waj?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    19 mins
  • Coexisting Comorbidities: Advancing Holistic Care in COPD

    Coexisting Comorbidities: Advancing Holistic Care in COPD
    Nov 24 2025

    Are you looking beyond the lung to provide holistic care for your patients with multimorbid chronic obstructive pulmonary disease (COPD)?

    Credit available for this activity expires: 11/26/2025
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/coexisting-comorbidities-advancing-holistic-care-copd-2025a1000uiz?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    34 mins
  • Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?

    Novel Biological Approaches for Enhanced Obesity and Diabetes Management – What's Next?
    Nov 24 2025

    Hear from our panel of obesity and diabetes experts about emerging obesity and type 2 diabetes therapies addressing cardiovascular, hepatic, and metabolic complications.

    Credit available for this activity expires: 11/25/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003022?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    39 mins
  • Latest Advances in mHSPC: An Update From Berlin 2025

    Latest Advances in mHSPC: An Update From Berlin 2025
    Nov 20 2025

    Does the year 2025 mark a true, tangible shift toward biomarker-driven precision medicine for metastatic hormone-sensitive prostate cancer (mHSPC)?

    Credit available for this activity expires: 11/18/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/latest-advances-mhspc-update-berlin-2025-2025a1000vlk?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    20 mins
  • Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC

    Conference Insights: Breaking Developments in ALK-Positive NSCLC and ES-SCLC
    Nov 20 2025

    Are you staying up to date on the latest practice-changing data revolutionizing the treatment for lung cancer?

    Credit available for this activity expires: 11/18/26
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/conference-insights-breaking-developments-alk-positive-nsclc-2025a1000vwn?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    35 mins
  • Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond

    Charting the Course for Metastatic Breast Cancer Care: Optimizing First-Line Treatment and Beyond
    Nov 17 2025

    ADCs as first-line treatment? ESR1 monitoring before progression? Local therapy for CNS disease? Experts tackle today's toughest decisions.

    Credit available for this activity expires: 11/14/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-metastatic-breast-cancer-care-optimizing-2025a1000v4s?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    1 hr and 17 mins
  • Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication

    Paving the Way for Success in Integrating Biosimilars Into Multiple Sclerosis Care: Optimizing Communication
    Nov 17 2025

    Do you know what words patients do not want to hear?

    Credit available for this activity expires: 11/13/2026
    Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/paving-way-success-integrating-biosimilars-multiple-2025a1000v8w?ecd=bdc_podcast_libsyn_mscpedu
    Show More Show Less
    38 mins